Haleon

Last updated
Haleon plc
Company type Public limited company
ISIN GB00BMX86B70
Industry
Predecessors
Founded18 July 2022;20 months ago (2022-07-18)
Headquarters Weybridge, Surrey, England
Area served
Worldwide
Key people
Products
Brands
RevenueIncrease2.svg £11,302 million (2023) [1]
Increase2.svg £1,996 million (2023) [1]
Decrease2.svg £1,111 million (2023) [1]
Total assets Decrease2.svg £34,055 million (2023) [1]
Total equity Increase2.svg £16,729 million (2023) [1]
Number of employees
24,000 (2023) [2]
Website www.haleon.com

Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. [3] It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins. [4] The company is a global leader in over the counter medicines with a 7.3 percent market share. [5]

Contents

Haleon was established on 18 July 2022 as a corporate spin-off from GSK. [6]

Sir David Lewis is chairman, with Brian McNamara as CEO. [7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020. [5]

History

GSK and Pfizer merged their consumer healthcare businesses in 2019. [8] [9] GSK owned just over two thirds of the joint venture, and Pfizer held the remainder. [8]

GSK announced plans to spin-off Haleon in 2018, in order to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division". [10]

Unilever offered £50 billion for the business in 2022, in a bid which GSK rejected. [11] Nestlé examined the possibility of a bid in conjunction with Reckitt. [12]

In October 2023, GSK reduced its ownership share in Haleon to just over 7.4%, [13] and again in January 2024 down to 4.2%. [14]

The ChapStick lip care brand was sold to Yellow Wood Partners for £401 million in 2024. [15]

In March 2024, Pfizer reduced its stake in Haleon from 32% to 24% by selling 630 million shares in a public offering. [16]

Operations

Oral health accounted for 28.5 percent of revenue in 2021. [17]

Brands

A selection of Aquafresh toothpaste and toothbrushes produced by Haleon Aquafresh - GSK.jpg
A selection of Aquafresh toothpaste and toothbrushes produced by Haleon

Brands include: [18]

Related Research Articles

<span class="mw-page-title-main">Common cold</span> Common viral infection of the upper respiratory tract

The common cold or the cold is a viral infectious disease of the upper respiratory tract that primarily affects the respiratory mucosa of the nose, throat, sinuses, and larynx. Signs and symptoms may appear fewer than two days after exposure to the virus. These may include coughing, sore throat, runny nose, sneezing, headache, and fever. People usually recover in seven to ten days, but some symptoms may last up to three weeks. Occasionally, those with other health problems may develop pneumonia.

<span class="mw-page-title-main">GSK plc</span> UK healthcare company

GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

<span class="mw-page-title-main">Route of administration</span> Path by which a drug, fluid, poison, or other substance is taken into the body

In pharmacology and toxicology, a route of administration is the way by which a drug, fluid, poison, or other substance is taken into the body.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.

<span class="mw-page-title-main">Upper respiratory tract infection</span> Medical condition

An upper respiratory tract infection (URTI) is an illness caused by an acute infection, which involves the upper respiratory tract, including the nose, sinuses, pharynx, larynx or trachea. This commonly includes nasal obstruction, sore throat, tonsillitis, pharyngitis, laryngitis, sinusitis, otitis media, and the common cold. Most infections are viral in nature, and in other instances, the cause is bacterial. URTIs can also be fungal or helminthic in origin, but these are less common.

ChapStick is a brand name of lip balm manufactured by Suave Brands Company, a subsidiary of private equity firm Yellow Wood Partners, and is used in many countries worldwide. It is intended to help treat and prevent chapped lips, hence the name. Many varieties also include sunscreen in order to prevent sunburn.

<span class="mw-page-title-main">Cefuroxime axetil</span> Chemical compound

Cefuroxime axetil, sold under the brand name Ceftin among others, is a second generation oral cephalosporin antibiotic.

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

Emergen-C is an effervescent, powdered drink mix vitamin supplement manufactured by Alacer Corp. The Emergen-C product line was introduced in 1978. Alacer was established as a private company in 1972, focusing on vitamin supplements containing vitamin C. The company was acquired by Pfizer in 2012. In 2019, Pfizer consumer healthcare entered a joint venture with GSK. The brand is owned by Haleon since 18 July 2022.

Caltrate is a brand name calcium supplement sold by Haleon.

<span class="mw-page-title-main">Sensodyne</span> Dental hygiene product for sensitive teeth

Sensodyne is a brand name of toothpaste and mouthwash targeted at people with sensitive teeth. Sensodyne is owned by Haleon and is marketed under the name Shumitect in Japan.

<span class="mw-page-title-main">Vitamin K reaction</span> Medical condition

Vitamin K reactions are adverse side effects that may occur after injection with vitamin K. The liver utilizes vitamin K to produce coagulation factors that help the body form blood clots which prevent excessive bleeding. Vitamin K injections are administered to newborns as a preventative measure to reduce the risk of hemorrhagic disease of the newborn (HDN).

<span class="mw-page-title-main">Centrum (multivitamin)</span> Brand of multivitamins

Centrum is an American brand of multivitamins produced by Haleon. It was previously owned by Pfizer and GSK.

Imedeen is a beauty supplements company that sells nutricosmetics. It was developed in the 1980s by the Swedish biochemist Ake Dahlgren. The brand is owned by GlaxoSmithKline and headquartered in Brentford, Hounslow a suburb in the United Kingdom.

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others.

<span class="mw-page-title-main">Wyeth</span> American pharmaceutical company

Wyeth was a pharmaceutical company until it was purchased by Pfizer in 2009. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother. Its headquarters moved to Collegeville, Pennsylvania, and Madison, New Jersey, before its headquarters were consolidated with Pfizer's in New York City after the 2009 merger.

Ibuprofen/paracetamol, is a fixed-dose combination of two medications, ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), and paracetamol (acetaminophen). It is available as a generic medication and common brand names include Combiflam.

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.

A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year.

References

  1. 1 2 3 4 5 "Annual results 2023" (PDF). Haleon. Retrieved 29 February 2024.
  2. "Haleon plots massive layoffs in UK and beyond to save costs: report". Fierce Pharma. 13 July 2023. Retrieved 11 February 2024.
  3. "GSK announces independent Consumer Healthcare company is to be called Haleon | GSK". www.gsk.com. 22 February 2022. Retrieved 2023-02-21.
  4. Ralph, Alex (2 July 2022). "GlaxoSmithKline prepares to get back to basics with historic break-up". The Times . Retrieved 4 July 2022.
  5. 1 2 Cornell, Joe (15 July 2021). "GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022". Forbes . Retrieved 10 June 2022.
  6. "Prospectus" (PDF). GSK plc. p. 15. Retrieved 10 June 2022.
  7. Kleinman, Mark (3 May 2022). "GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks". Sky News . Retrieved 10 June 2022.
  8. 1 2 Shane, Daniel (19 December 2018). "Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses". CNN . Retrieved 10 June 2022.
  9. "Haleon Won't Indemnify Pfizer, GSK Over Zantac. Shares Are Up". Barron's. 20 September 2022. Retrieved 17 December 2022.
  10. Donnellan, Aimee (9 June 2022). "GSK castoff starts life with target on its back". Reuters . Retrieved 10 June 2022.
  11. Jolly, Jasper (19 January 2022). "Unilever will not increase £50bn offer for GSK consumer arm". The Guardian . Retrieved 10 June 2022.
  12. "Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit". Bloomberg News . 25 May 2022. Retrieved 10 June 2022.
  13. "GSK raises $1.1 billion from Haleon stake sale". Reuters. 2023-10-06. Retrieved 2023-10-09.
  14. "GSK raises $1.24 bln from latest Haleon stake sale". Reuters. 2024-01-17. Retrieved 2024-01-18.
  15. Williams, Holly (25 January 2024). "Haleon offloads ChapStick lip balm brand in £401m deal". The Standard. Retrieved 20 February 2024.
  16. "Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%". Yahoo Finance. 2024-03-18. Retrieved 2024-03-19.
  17. "Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon". GSK. 6 January 2022. Retrieved 10 June 2022.
  18. "Our Consumer Healthcare Brands". Haleon. Retrieved 19 July 2022.